December 23, 2024 03:03 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Mohali building collapse: Death toll rises to 2, many feared trapped for 17 hours | 4-year-old killed after speeding car driven by a teen hits him in Mumbai | PM Modi attends opening ceremony of Arabian Gulf Cup in Kuwait | Jaipur gas tanker crash: Toll touches 14, 30 critical | Arrest warrant against former cricketer Robin Uthappa over 'PF fraud' | PM Modi emplanes for a visit to Kuwait | German Christmas market car attack leaves 2 dead, Saudi Arabian doctor arrested | India, France come together to build world's largest museum in Delhi's Raisina Hill | Canada, US presented no evidence of Indians' involvement in purported criminal acts: Centre informs Parliament amid 'serious allegations' | Delhi Police Crime Branch to investigate FIR against Rahul Gandhi over Parliament tussle
Booster shot offers nine-fold increase in COVID-19 antibodies: Johnson & Johnson

Booster shot offers nine-fold increase in COVID-19 antibodies: Johnson & Johnson

Aug 26, 2021, at 12:28 am

Washington/UNI/Sputnik: US pharmaceutical giant Johnson & Johnson said on Wednesday that a study showed a nine-fold increase in COVID-19 antibodies in participants who took a booster dose of its single-shot COVID-19 vaccine.

Johnson & Johnson seeks approval for trial of COVID vaccine on adolescents in India

Johnson & Johnson seeks approval for trial of COVID vaccine on adolescents in India

Aug 21, 2021, at 01:49 am

New Delhi/IBNS: US pharma major Johnson & Johnson (J&J) has written to Central Drugs Standard Control Organisation's (CDSCO) seeking approval for the clinical trial of its COVID-19 single-shot Janssen vaccine among children aged 12 to 17 years.